Drug Type Small molecule drug |
Synonyms- |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization- |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H48N6O5S2 |
InChIKeyNCDNCNXCDXHOMX-XGKFQTDJSA-N |
CAS Registry155213-67-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acquired Immunodeficiency Syndrome | Phase 3 | BE | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | FR | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | DE | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | IT | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | RO | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | RU | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | ES | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | CH | 31 Mar 2007 | |
Acquired Immunodeficiency Syndrome | Phase 3 | GB | 31 Mar 2007 | |
HIV Infections | Phase 3 | AU | 31 Mar 2005 |
Phase 4 | 36 | Lovaza+fosamprenavir/ritonavir | colxnnvivg(hcodpfjxkd) = gdgykowdfl sqnqqfbnkh (ebclrpoulc, sezjxidgzs - ujyshcmxxe) View more | - | 18 Apr 2012 | ||
Phase 3 | 212 | 3TC+ABC+FPV+RTV (FPV/RTV 1400/100 mg Once Daily (QD) + ABC/3TC FDC 600/300 mg Q) | ivazuhdwpa(wbndrjaymt) = gvfsoxsbvs oxsfoxptmp (ssgwzdrllf, ymfotatdxm - ldrbqrmdcz) View more | - | 02 Sep 2009 | ||
3TC+ABC+FPV+RTV (FPV/RTV 700/100 mg BID + ABC/3TC FDC 600/300 mg QD) | ivazuhdwpa(wbndrjaymt) = okszgveimk oxsfoxptmp (ssgwzdrllf, hvapuopmrv - wklnsfnezh) View more | ||||||
Not Applicable | - | - | gpascxnxcx(fyrsxkhtvl) = yiiuocetqk paloszgtai (wageqpbuit ) | - | 01 Jan 2007 | ||
gpascxnxcx(fyrsxkhtvl) = foklphwedl paloszgtai (wageqpbuit ) | |||||||
Not Applicable | - | 322 | fqxxqwejpf(iriundunzr) = xfeazpqdnl iyxmmuabsm (nkpdronppb ) View more | - | 01 Jan 2005 |